General Information of This Antigen
Antigen ID
TAR0EBTXG
Antigen Name
B-lymphocyte antigen CD19 (CD19)
Gene Name
CD19
Gene ID
930
Synonym
B-lymphocyte surface antigen B4; Differentiation antigen CD19;T-cell surface antigen Leu-12;CD_antigen=CD19
Sequence
MPPPRLLFFLLFLTPMEVRPEEPLVVKVEEGDNAVLQCLKGTSDGPTQQLTWSRESPLKP
FLKLSLGLPGLGIHMRPLAIWLFIFNVSQQMGGFYLCQPGPPSEKAWQPGWTVNVEGSGE
LFRWNVSDLGGLGCGLKNRSSEGPSSPSGKLMSPKLYVWAKDRPEIWEGEPPCLPPRDSL
NQSLSQDLTMAPGSTLWLSCGVPPDSVSRGPLSWTHVHPKGPKSLLSLELKDDRPARDMW
VMETGLLLPRATAQDAGKYYCHRGNLTMSFHLEITARPVLWHWLLRTGGWKVSAVTLAYL
IFCLCSLVGILHLQRALVLRRKRKRMTDPTRRFFKVTPPPGSGPQNQYGNVLSLPTPTSG
LGRAQRWAAGLGGTAPSYGNPSSDVQADGALGSRSPPGVGPEEEEGEGYEEPDSEEDSEF
YENDSNLGQDQLSQDGSGYENPEDEPLGPEDEDSFSNAESYENEDEELTQPVARTMDFLS
PHGSAWDPSREATSLGSQSYEDMRGILYAAPQLRSIRGQPGPNHEEDADSYENMDNPDGP
DPAWGGGGRMGTWSTR

    Click to Show/Hide
Function
Functions as coreceptor for the B-cell antigen receptor complex (BCR) on B-lymphocytes. Decreases the threshold for activation of downstream signaling pathways and for triggering B-cell responses to antigens. Activates signaling pathways that lead to the activation of phosphatidylinositol 3-kinase and the mobilization of intracellular Ca(2+) stores. Is not required for early steps during B cell differentiation in the blood marrow. Required for normal differentiation of B-1 cells. Required for normal B cell differentiation and proliferation in response to antigen challenges. Required for normal levels of serum immunoglobulins, and for production of high-affinity antibodies in response to antigen challenge.

    Click to Show/Hide
Uniprot Entry
CD19_HUMAN
HGNC ID
HGNC:1633
KEGG ID
hsa:930
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
ADC Info ADC Name Payload Target Linker Ref
AFM-11-2i
Monomethyl auristatin F
Microtubule (MT)
AFM-11-2i linker
[1]
AFM-11-4i
Monomethyl auristatin F
Microtubule (MT)
AFM-11-4i linker
[1]
AFM-11-3i
Monomethyl auristatin F
Microtubule (MT)
AFM-11-3i linker
[1]
AFM-11-6e
Monomethyl auristatin E
Microtubule (MT)
AFM-11-6e linker
[1]
AFM-11-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
AFM-11-amanitin linker
[1]
ADC Info ADC Name Payload Target Linker Ref
AFM-12-2i
Monomethyl auristatin F
Microtubule (MT)
AFM-12-2i linker
[1]
AFM-12-4i
Monomethyl auristatin F
Microtubule (MT)
AFM-12-4i linker
[1]
AFM-12-3i
Monomethyl auristatin F
Microtubule (MT)
AFM-12-3i linker
[1]
AFM-12-6e
Monomethyl auristatin E
Microtubule (MT)
AFM-12-6e linker
[1]
AFM-12-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
AFM-12-amanitin linker
[1]
Anti-CD19 antibody
ADC Info ADC Name Payload Target Linker Ref
LCB73
PBD dimer
Human deoxyribonucleic acid (hDNA)
β-glucuronide trigger linker
B43-genistein
Genistein
isoflavone tyrosine kinase
Undisclosed
Anti-CD19 IgG1 mAb
ADC Info ADC Name Payload Target Linker Ref
ABBV-319
Glucocorticoid receptor modulator
Glucocorticoid receptor (NR3C1)
MP-Ala-Ala
Anti-CD19 mAb B4
ADC Info ADC Name Payload Target Linker Ref
B4-SPP-DC44
DC44
Human Deoxyribonucleic acid (hDNA)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
[2]
B4-SMCC-DC4
Phosphate prodrugs 40 (DC4)
Human Deoxyribonucleic acid (hDNA)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
[2]
B4-SPP-DC4
Phosphate prodrugs 40 (DC4)
Human Deoxyribonucleic acid (hDNA)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
[2]
B4-SPP-DC1
DC1
Human Deoxyribonucleic acid (hDNA)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
[2]
Anti-CD19 mAb DI-B4
ADC Info ADC Name Payload Target Linker Ref
LCB14-0648
Monomethyl auristatin F
Microtubule (MT)
LCB14-0648 linker
[1]
LCB14-0663
Monomethyl auristatin F
Microtubule (MT)
LCB14-0663 linker
[1]
LCB14-0664
Monomethyl auristatin F
Microtubule (MT)
LCB14-0664 linker
[1]
LCB14-6e
Monomethyl auristatin E
Microtubule (MT)
LCB14-6e linker
[1]
LCB14-alpha-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
LCB14-alpha-amanitin linker
[1]
WO2017089895A1 ADC67
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC67 linker
[3]
WO2017089895A1 ADC68
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC68 linker
[3]
WO2017089895A1 ADC69
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC69 linker
[3]
WO2017089890A1 ADC67
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC67 linker
[4]
WO2017089890A1 ADC68
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC68 linker
[4]
WO2017089890A1 ADC69
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC69 linker
[4]
Anti-CD19 mAb hA19
ADC Info ADC Name Payload Target Linker Ref
HA19-SN38 antibody-drug conjugate
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
CL2A
[5]
Anti-CD19 mAb hBU12
ADC Info ADC Name Payload Target Linker Ref
HBU12-mc-MMAF
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
[6]
ADC Info ADC Name Payload Target Linker Ref
CHD37-2i
Monomethyl auristatin F
Microtubule (MT)
cHD37-2i linker
[1]
CHD37-4i
Monomethyl auristatin F
Microtubule (MT)
cHD37-4i linker
[1]
CHD37-3i
Monomethyl auristatin F
Microtubule (MT)
cHD37-3i linker
[1]
CHD37-6e
Monomethyl auristatin E
Microtubule (MT)
cHD37-6e linker
[1]
CHD37-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
cHD37-amanitin linker
[1]
Coltuximab
ADC Info ADC Name Payload Target Linker Ref
Coltuximab ravtansine
DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
JP7623413B2 ExampleADC49
Undisclosed
Undisclosed
Undisclosed
[7]
JP7560255B2 ControlADC49
Undisclosed
Undisclosed
Undisclosed
[8]
Denintuzumab
ADC Info ADC Name Payload Target Linker Ref
Denintuzumab mafodotin
MMAF
Microtubule (MT)
Maleimido-caproyl
Denintuzumab-2i
Monomethyl auristatin F
Microtubule (MT)
Denintuzumab-2i linker
[1]
Denintuzumab-4i
Monomethyl auristatin F
Microtubule (MT)
Denintuzumab-4i linker
[1]
Denintuzumab-3i
Monomethyl auristatin F
Microtubule (MT)
Denintuzumab-3i linker
[1]
Denintuzumab-6e
Monomethyl auristatin E
Microtubule (MT)
Denintuzumab-6e linker
[1]
Denintuzumab-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Denintuzumab-amanitin linker
[1]
hBU12-mcMMAF
Monomethyl auristatin F
Microtubule (MT)
Maleimido-caproyl
[9]
hBU12-MC-vc-PABC-MMAE
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
[9]
hBU12-MC-vc-PABC-MMAF DAR4
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
[9]
hBU12-1 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Phe-Dpr-MA
[9]
hBU12-1 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Phe-Dpr-MA
[9]
hBU12-2 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Phe-Glu-Dpr-MA
[9]
hBU12-2 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Phe-Glu-Dpr-MA
[9]
hBU12-3 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Thr-Dpr-MA
[9]
hBU12-3 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Thr-Dpr-MA
[9]
hBU12-4 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-Dpr-MA
[9]
hBU12-4 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-Dpr-MA
[9]
hBU12-5 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Phe-Glu-Dpr-MDpr
[9]
hBU12-5 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Phe-Glu-Dpr-MDpr
[9]
hBU12-6 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-Dpr-MDpr
[9]
hBU12-6 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-Dpr-MDpr
[9]
hBU12-7 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-Lys-MDpr
[9]
hBU12-7 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-Lys-MDpr
[9]
hBU12-8 MMAE
Monomethyl auristatin E
Microtubule (MT)
Thiazole-Glu-Lys-MDpr
[9]
hBU12-9 MMAE
Monomethyl auristatin E
Microtubule (MT)
Phe-Glu-EDA-MDpr
[9]
hBU12-10 MMAE
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-EDA-MDpr
[9]
hBU12-11 MMAE
Monomethyl auristatin E
Microtubule (MT)
Phe-Ile-EDA-MDpr
[9]
hBU12-12 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Thr-Ile-EDA-MDpr
[9]
hBU12-13 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Thiazole-Glu-EDA-MDpr
[9]
hBU12-14 MMAE
Monomethyl auristatin E
Microtubule (MT)
Asp-Ala-Lys-MDpr
[9]
hBU12-15 MMAE
Monomethyl auristatin E
Microtubule (MT)
Glu-Ala-Lys-MDpr
[9]
hBU12-16 MMAE
Monomethyl auristatin E
Microtubule (MT)
PhosphoThr-Ala-Lys-MDpr
[9]
hBU12-17 MMAE
Monomethyl auristatin E
Microtubule (MT)
Asn-AlaGlu-Dpr-MDpr
[9]
hBU12-18 MMAE
Monomethyl auristatin E
Microtubule (MT)
Glu-Ala-Glu-Dpr-MDpr
[9]
hBU12-19 MMAE
Monomethyl auristatin E
Microtubule (MT)
Asp-AlaGlu-Dpr-MDpr
[9]
hBU12-20 MMAE
Monomethyl auristatin E
Microtubule (MT)
Glu-Ala-Glu-Dpr-MDpr
[9]
hBU12-21 MMAE
Monomethyl auristatin E
Microtubule (MT)
hSer-Ala-Glu-Dpr-MDpr
[9]
hBU12-22 MMAE
Monomethyl auristatin E
Microtubule (MT)
ValoH-AlaGlu-Dpr-MDpr
[9]
hBU12-23 MMAE
Monomethyl auristatin E
Microtubule (MT)
PhosphoThr-Ala-Glu-Dpr-MDpr
[9]
hBU12-24 MMAE
Monomethyl auristatin E
Microtubule (MT)
Pyrazole-Glu-Dpr-MDpr
[9]
hBU12-25 MMAE
Monomethyl auristatin E
Microtubule (MT)
Triazole-Glu-Dpr-MDpr
[9]
hBU12-26 MMAE
Monomethyl auristatin E
Microtubule (MT)
Asn-Glu-Dpr-MDpr
[9]
hBU12-27 MMAE
Monomethyl auristatin E
Microtubule (MT)
Asp-Glu-Dpr-MDpr
[9]
hBU12-28 MMAE
Monomethyl auristatin E
Microtubule (MT)
Fur-Glu-Dpr-MDpr
[9]
hBU12-29 MMAE
Monomethyl auristatin E
Microtubule (MT)
ValOH-Glu-Dpr-MDpr
[9]
hBU12-30 MMAE
Monomethyl auristatin E
Microtubule (MT)
Ser-Glu-Dpr-MDpr
[9]
hBU12-31 MMAE
Monomethyl auristatin E
Microtubule (MT)
hSer-Glu-Dpr-MDpr
[9]
hBU12-32 MMAE
Monomethyl auristatin E
Microtubule (MT)
Thr-IleLeu-Dpr-MDpr
[9]
hBU12-33 MMAE
Monomethyl auristatin E
Microtubule (MT)
Phe-Ile-Leu-Dpr-MDpr
[9]
hBU12-34 MMAE
Monomethyl auristatin E
Microtubule (MT)
Glu-Phe-Leu-Dpr-MDpr
[9]
hBU12-35 MMAE
Monomethyl auristatin E
Microtubule (MT)
Thr-LeuPhe-Dpr-MDpr
[9]
hBU12-36 MMAE
Monomethyl auristatin E
Microtubule (MT)
Phe-Leu-Phe-Dpr-MDpr
[9]
hBU12-37 MMAE
Monomethyl auristatin E
Microtubule (MT)
Glu-Phe-Phe-Dpr-MDpr
[9]
hBU12-38 MMAE
Monomethyl auristatin E
Microtubule (MT)
Thr-LysAla-Dpr-MDpr
[9]
hBU12-39 MMAE
Monomethyl auristatin E
Microtubule (MT)
Thr-Lys-Dpr-MDpr
[9]
hBU12-1 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Dpr-MA
[9]
hBU12-2 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Glu-Dpr-MA
[9]
hBU12-3 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Dpr-MA
[9]
hBU12-4 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Glu-Dpr-MA
[9]
hBU12-5 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Glu-Dpr-MDpr
[9]
hBU12-6 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Glu-Dpr-MDpr
[9]
hBU12-7 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Glu-Lys-MDpr
[9]
hBU12-8 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thiazole-Glu-Lys-MDpr
[9]
hBU12-9 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Glu-EDA-MDpr
[9]
hBU12-10 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Glu-EDA-MDpr
[9]
hBU12-11 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Ile-EDA-MDpr
[9]
hBU12-12 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Ile-EDA-MDpr
[9]
hBU12-13 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thiazole-Glu-EDA-MDpr
[9]
hBU12-14 MMAF
Monomethyl auristatin F
Microtubule (MT)
Asp-Ala-Lys-MDpr
[9]
hBU12-15 MMAF
Monomethyl auristatin F
Microtubule (MT)
Glu-Ala-Lys-MDpr
[9]
hBU12-16 MMAF
Monomethyl auristatin F
Microtubule (MT)
PhosphoThr-Ala-Lys-MDpr
[9]
hBU12-17 MMAF
Monomethyl auristatin F
Microtubule (MT)
Asn-AlaGlu-Dpr-MDpr
[9]
hBU12-18 MMAF
Monomethyl auristatin F
Microtubule (MT)
Glu-Ala-Glu-Dpr-MDpr
[9]
hBU12-19 MMAF
Monomethyl auristatin F
Microtubule (MT)
Asp-AlaGlu-Dpr-MDpr
[9]
hBU12-20 MMAF
Monomethyl auristatin F
Microtubule (MT)
Glu-Ala-Glu-Dpr-MDpr
[9]
hBU12-21 MMAF
Monomethyl auristatin F
Microtubule (MT)
hSer-Ala-Glu-Dpr-MDpr
[9]
hBU12-22 MMAF
Monomethyl auristatin F
Microtubule (MT)
ValoH-AlaGlu-Dpr-MDpr
[9]
hBU12-23 MMAF
Monomethyl auristatin F
Microtubule (MT)
PhosphoThr-Ala-Glu-Dpr-MDpr
[9]
hBU12-24 MMAF
Monomethyl auristatin F
Microtubule (MT)
Pyrazole-Glu-Dpr-MDpr
[9]
hBU12-25 MMAF
Monomethyl auristatin F
Microtubule (MT)
Triazole-Glu-Dpr-MDpr
[9]
hBU12-26 MMAF
Monomethyl auristatin F
Microtubule (MT)
Asn-Glu-Dpr-MDpr
[9]
hBU12-27 MMAF
Monomethyl auristatin F
Microtubule (MT)
Asp-Glu-Dpr-MDpr
[9]
hBU12-28 MMAF
Monomethyl auristatin F
Microtubule (MT)
Fur-Glu-Dpr-MDpr
[9]
hBU12-29 MMAF
Monomethyl auristatin F
Microtubule (MT)
ValOH-Glu-Dpr-MDpr
[9]
hBU12-30 MMAF
Monomethyl auristatin F
Microtubule (MT)
Ser-Glu-Dpr-MDpr
[9]
hBU12-31 MMAF
Monomethyl auristatin F
Microtubule (MT)
hSer-Glu-Dpr-MDpr
[9]
hBU12-32 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-IleLeu-Dpr-MDpr
[9]
hBU12-33 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Ile-Leu-Dpr-MDpr
[9]
hBU12-34 MMAF
Monomethyl auristatin F
Microtubule (MT)
Glu-Phe-Leu-Dpr-MDpr
[9]
hBU12-35 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-LeuPhe-Dpr-MDpr
[9]
hBU12-36 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Leu-Phe-Dpr-MDpr
[9]
hBU12-37 MMAF
Monomethyl auristatin F
Microtubule (MT)
Glu-Phe-Phe-Dpr-MDpr
[9]
hBU12-38 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-LysAla-Dpr-MDpr
[9]
hBU12-39 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Lys-Dpr-MDpr
[9]
hBU12-MC-vc-PABC-MMAF DAR8
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
[9]
hBU12-13 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Thiazole-Glu-EDA-MDpr
[9]
hBU12-12 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Thr-Ile-EDA-MDpr
[9]
hBU12-11 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Phe-Ile-EDA-MDpr
[9]
hBU12-17 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Asn-AlaGlu-Dpr-MDpr
[9]
hBU12-20 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Glu-Ala-Glu-Dpr-MDpr
[9]
hBU12-24 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Pyrazole-Glu-Dpr-MDpr
[9]
hBU12-29 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
ValOH-Glu-Dpr-MDpr
[9]
JP7623413B2 ExampleADC50
Undisclosed
Undisclosed
Undisclosed
[7]
DI-B4-(LC)-GGGGGGG-CVIM
ADC Info ADC Name Payload Target Linker Ref
Anti-CD19(LC)-G7VIM-2i
Monomethyl auristatin F
Microtubule (MT)
Anti-CD19(LC)-G7VIM-2i linker
[1]
Anti-CD19(LC)-G7VIM-4i
Monomethyl auristatin F
Microtubule (MT)
Anti-CD19(LC)-G7VIM-4i linker
[1]
Anti-CD19(LC)-G7VIM-3i
Monomethyl auristatin F
Microtubule (MT)
Anti-CD19(LC)-G7VIM-3i linker
[1]
Anti-CD19(LC)-G7VIM-6e
Monomethyl auristatin E
Microtubule (MT)
Anti-CD19(LC)-G7VIM-6e linker
[1]
Anti-CD19(LC)-G7VIM-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Anti-CD19(LC)-G7VIM-amanitin linker
[1]
ADC Info ADC Name Payload Target Linker Ref
GBR401-2i
Monomethyl auristatin F
Microtubule (MT)
GBR401-2i linker
[1]
GBR401-4i
Monomethyl auristatin F
Microtubule (MT)
GBR401-4i linker
[1]
GBR401-3i
Monomethyl auristatin F
Microtubule (MT)
GBR401-3i linker
[1]
GBR401-6e
Monomethyl auristatin E
Microtubule (MT)
GBR401-6e linker
[1]
GBR401-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
GBR401-amanitin linker
[1]
ADC Info ADC Name Payload Target Linker Ref
TW201803600A ADC-5
PBD
Undisclosed
Undisclosed
[10]
ADC Info ADC Name Payload Target Linker Ref
SGN-CD19B
SGD-1882
Human deoxyribonucleic acid (hDNA)
Mc-Val-Ala
Inebilizumab
ADC Info ADC Name Payload Target Linker Ref
Inebilizumab-2i
Monomethyl auristatin F
Microtubule (MT)
Inebilizumab-2i linker
[1]
Inebilizumab-4i
Monomethyl auristatin F
Microtubule (MT)
Inebilizumab-4i linker
[1]
Inebilizumab-3i
Monomethyl auristatin F
Microtubule (MT)
Inebilizumab-3i linker
[1]
Inebilizumab-6e
Monomethyl auristatin E
Microtubule (MT)
Inebilizumab-6e linker
[1]
Inebilizumab-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Inebilizumab-amanitin linker
[1]
Loncastuximab
ADC Info ADC Name Payload Target Linker Ref
Loncastuximab tesirine
SG3199 (SC-DR002)
Human deoxyribonucleic acid (hDNA)
Mal-PEG8-Val-Ala-PABC
loncastuximab
ADC Info ADC Name Payload Target Linker Ref
IGAC-88
IG-L-18 Payload
Undisclosed
IG-L-25 linker
[11]
ADC Info ADC Name Payload Target Linker Ref
MDX-1342-2i
Monomethyl auristatin F
Microtubule (MT)
MDX-1342-2i linker
[1]
MDX-1342-4i
Monomethyl auristatin F
Microtubule (MT)
MDX-1342-4i linker
[1]
MDX-1342-3i
Monomethyl auristatin F
Microtubule (MT)
MDX-1342-3i linker
[1]
MDX-1342-6e
Monomethyl auristatin E
Microtubule (MT)
MDX-1342-6e linker
[1]
MDX-1342-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
MDX-1342-amanitin linker
[1]
ADC Info ADC Name Payload Target Linker Ref
MDX-1435-2i
Monomethyl auristatin F
Microtubule (MT)
MDX-1435-2i linker
[1]
MDX-1435-4i
Monomethyl auristatin F
Microtubule (MT)
MDX-1435-4i linker
[1]
MDX-1435-3i
Monomethyl auristatin F
Microtubule (MT)
MDX-1435-3i linker
[1]
MDX-1435-6e
Monomethyl auristatin E
Microtubule (MT)
MDX-1435-6e linker
[1]
MDX-1435-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
MDX-1435-amanitin linker
[1]
Mouse CD19 antibody
ADC Info ADC Name Payload Target Linker Ref
37788373 ADC1
(R)-Budesonide
Undisclosed
MC-Val-Cit-RG-1
[12]
37788373 ADC2
(R)-Budesonide
Undisclosed
MC-Val-Ala-RG-1
[12]
37788373 ADC3
(R)-Budesonide
Undisclosed
MC-Ala-Ala-RG-1
[12]
37788373 ADC4
(R)-Budesonide
Undisclosed
Mc-Val-Glu-RG-1
[12]
37788373 ADC5
(R)-Budesonide
Undisclosed
MC-Ser-Cit-RG-1
[12]
37788373 ADC6
(R)-Budesonide
Undisclosed
MP-Ala-Ala-RG-1
[12]
37788373 ADC7
(R)-Budesonide
Undisclosed
MP-Asn-Cit-RG-1
[12]
37788373 ADC8
(R)-Budesonide
Undisclosed
MP-Gln-Cit-RG-1
[12]
37788373 ADC9
Triamcinolone acetonide
Undisclosed
MC-Ala-Ala-RG-1
[12]
37788373 ADC10
(S)-Budesonide
Undisclosed
MC-Ala-Ala-RG-1
[12]
37788373 ADC11
(R)-Budesonide
Undisclosed
MC-Ala-Ala-RG-2
[12]
37788373 ADC12
(R)-Budesonide
Undisclosed
MC-Ala-Ala-RG-4
[12]
37788373 ADC13
(R)-Budesonide
Undisclosed
MC-Ala-Ala-RG-6
[12]
37788373 ADC14
(R)-Budesonide
Undisclosed
MC-Val-Cit-RG-7
[12]
37788373 ADC15
(R)-Budesonide
Undisclosed
MC-Val-Ala-RG-8
[12]
37788373 ADC16
(R)-Budesonide
Undisclosed
MC-Val-Ala-RG-9
[12]
37788373 ADC17
(R)-Budesonide
Undisclosed
MC-Val-Cit-RG-10
[12]
37788373 ADC18
(R)-Budesonide
Undisclosed
MC-Val-Cit-RG-11
[12]
37788373 ADC19
(R)-Budesonide
Undisclosed
MC-Val-Ala-RG-12
[12]
37788373 ADC20
(R)-Budesonide
Undisclosed
MC-Val-Ala-RG-13
[12]
37788373 ADC21
(R)-Budesonide
Undisclosed
MC-Val-Ala-RG-14
[12]
37788373 ADC22
(R)-Budesonide
Undisclosed
MC-Val-Ala-RG-15
[12]
37788373 ADC23
(R)-Budesonide
Undisclosed
MP-Ala-Ala-RG-9
[12]
Obexelimab
ADC Info ADC Name Payload Target Linker Ref
Obexelimab-2i
Monomethyl auristatin F
Microtubule (MT)
Obexelimab-2i linker
[1]
Obexelimab-4i
Monomethyl auristatin F
Microtubule (MT)
Obexelimab-4i linker
[1]
Obexelimab-3i
Monomethyl auristatin F
Microtubule (MT)
Obexelimab-3i linker
[1]
Obexelimab-6e
Monomethyl auristatin E
Microtubule (MT)
Obexelimab-6e linker
[1]
Obexelimab-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Obexelimab-amanitin linker
[1]
ADC Info ADC Name Payload Target Linker Ref
RC58-ADC-1
Dumycin-7
Human Deoxyribonucleic acid (hDNA)
Bis-bromine linker-PEG4-Asn-Ala-ethylenediamine
[13]
RC58-ADC-3
Duostain 3
Undisclosed
Bis-bromine linker-mono-glycine-PEG12-PAB
[13]
RC58-ADC-2
Duostain 3
Undisclosed
Bis-bromine linker-PEG2-VC-PAB
[13]
Tafasitamab
ADC Info ADC Name Payload Target Linker Ref
Tafasitamab-2i
Monomethyl auristatin F
Microtubule (MT)
Tafasitamab-2i linker
[1]
Tafasitamab-4i
Monomethyl auristatin F
Microtubule (MT)
Tafasitamab-4i linker
[1]
Tafasitamab-3i
Monomethyl auristatin F
Microtubule (MT)
Tafasitamab-3i linker
[1]
Tafasitamab-6e
Monomethyl auristatin E
Microtubule (MT)
Tafasitamab-6e linker
[1]
Tafasitamab-amanitin
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Tafasitamab-amanitin linker
[1]
Undisclosed
ADC Info ADC Name Payload Target Linker Ref
LCB-73
Undisclosed
Undisclosed
Undisclosed
[14]
NI-2201
Undisclosed
Undisclosed
Undisclosed
[15]
TE-1522
Undisclosed
Undisclosed
Undisclosed
[16]
HuB4-DGN462
DGN462
Human Deoxyribonucleic acid (hDNA)
Sulfo-SPDB
[17]
Anti-B4 monoclonal antibody-DC1 conjugate
DC1
Human Deoxyribonucleic acid (hDNA)
Undisclosed
[18]
NV102
Doxorubicin
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
[19]
CD19-ATAC
HDP 30.2115
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Mal-Val-Ala-PAB
[20]
Anti-CD19 monoclonal antibody-liposomal sodium butyrate conjugate
Sodium butyrate
Histone deacetylase 1 (HDAC1)
Undisclosed
[21]
CO-1008
Undisclosed
Undisclosed
Undisclosed
[22]
B cell High Density Microparticles
Undisclosed
Undisclosed
Undisclosed
[23]
undisclosed
ADC Info ADC Name Payload Target Linker Ref
CD19 mAb-TP
Triptolide
Nuclear factor NF-kappa-B p105 subunit (NFKB1)
PEG2000-NHS
[24]
CN119365219A+ADC
Undisclosed
Undisclosed
Mc-Gly-Gly-Phe-Gly
[25]
References
Ref 1 Compositions and methods related to anti-cd19 antibody drug conjugates; 2017-03-30.
Ref 2 Synthesis and biological evaluation of antibody conjugates of phosphate prodrugs of cytotoxic DNA alkylators for the targeted treatment of cancer. J Med Chem. 2012 Jan 26;55(2):766-82.
Ref 3 Antibody-drug conjugates comprising branched linkers and methods related thereto; 2017-06-01.
Ref 4 Conjugates comprising self-immolative groups and methods related thereto.
Ref 5 Introduction to basic information on ADC drug hA19-SN-38 antibody-drug conjugate - Immunomedics.
Ref 6 A coiled-coil masking domain for selective activation of therapeutic antibodies. Nat Biotechnol. 2019 Jul;37(7):761-765. doi: 10.1038/s41587-019-0135-x. Epub 2019 May 27.
Ref 7 Antibody-drug complexes containing hemiasterlin derivatives
Ref 8 Pharmaceuticals containing antibody-drug complexes containing hemiasterin derivatives
Ref 9 Hydrophilic antibody-drug conjugates; 2015-08-20.
Ref 10 Antibody-drug conjugates mainly based on PBD and combinations with FLT3 inhibitors
Ref 11 Isoindolinone-glutarimide antibody conjugates, and uses thereof
Ref 12 Self-Immolative Carbamate Linkers for CD19-Budesonide Antibody-Drug Conjugates
Ref 13 Development of novel anti-CD19 antibody-drug conjugates for B-cell lymphoma treatment. Int Immunopharmacol. 2018 Sep;62:299-308. doi: 10.1016/j.intimp.2018.06.034. Epub 2018 Jul 23.
Ref 14 LegoChem Biosciences and Iksuda enter Licensing Agreement for Antibody Drug Conjugate program; 27 Jan 2021.
Ref 15 Lightchain biosciences biotechnology company product pipeline
Ref 16 Introduction to basic information on ADC drug TE-1522.
Ref 17 The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models. Haematologica. 2019 Aug;104(8):1633-1639. doi: 10.3324/haematol.2018.211011. Epub 2019 Feb 7.
Ref 18 Introduction to basic information on anti-B4 monoclonal antibody-DC1 conjugate (Anti-B4-DC1).
Ref 19 ADC review: basic information about NV102 (Doxorubicin-Anti-CD19).
Ref 20 CD19 - a potential target for Amanitin-based ADCs. Cancer Res (2017) 77 (13_Supplement): 62.
Ref 21 Effect of liposomes containing sodium butyrate conjugated with anti-CD19 monoclonal antibody on in vitro and in vivo growth of malignant lymphoma. Cancer Res. 1990 Jun 1;50(11):3245-8.
Ref 22 Progression towards the clinic by 2025 with a strategy for rapid FIH data acquisition.
Ref 23 Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with non-Hodgkin's lymphoma. Biol Blood Marrow Transplant. 2002;8(8):429-34. doi: 10.1053/bbmt.2002.v8.pm12234168.
Ref 24 A rationally designed CD19 monoclonal antibody-triptolide conjugate for the treatment of systemic lupus erythematosus
Ref 25 Anti-CD19 antibody-drug conjugates